| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/05/2007 | WO2007073661A1 Activated collagen scaffold materials and their special fused active restoration factors |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007057436A3 Interferon in influenza |
| 07/05/2007 | WO2007056433A3 Methods of treating tissue defects |
| 07/05/2007 | WO2007056105A3 Human growth hormone patch formulations |
| 07/05/2007 | WO2007044321A3 Latent procytotoxins and uses thereof |
| 07/05/2007 | WO2007039318A3 Neuropeptide y analogs |
| 07/05/2007 | WO2007036028A9 Compositions for and methods of granzyme b inhibition |
| 07/05/2007 | WO2007027574B1 Cyclic peptide isolation by spray drying |
| 07/05/2007 | WO2007013358A3 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 07/05/2007 | WO2007000320A3 Method for diagnosing rheumatic diseases |
| 07/05/2007 | WO2006138709A3 Lkktet and/or lkktnt peptide compositions and methods |
| 07/05/2007 | WO2006136161A3 Amylases for pharmaceutical use |
| 07/05/2007 | WO2006126198A3 Arts c-terminus fragments and mimetics thereof |
| 07/05/2007 | WO2006125077A3 Non-natural chemokine receptor ligands and methods of use thereof |
| 07/05/2007 | WO2006121552A3 Abuse-resistant amphetamine prodrugs |
| 07/05/2007 | WO2006061717A3 Materials and methods related to dickkopfs (dkk) and neurogenesis |
| 07/05/2007 | WO2006052391A3 Heterocyclic inhibitors of ires-mediated translation and methods of use thereof |
| 07/05/2007 | WO2006047558A3 Methods for detecting a trial fibrillation and related conditions |
| 07/05/2007 | WO2006033669A3 Method of modulating vascularization |
| 07/05/2007 | WO2006017619A3 Receptor-binding cyclic peptides and methods of use |
| 07/05/2007 | WO2005110469A3 Methods and compositions for reducing oxalate concentrations |
| 07/05/2007 | WO2004083381A3 Fibroblast growth factor receptor-1 polynucleotides, polypeptides, and mutants |
| 07/05/2007 | WO2003066821A3 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same |
| 07/05/2007 | WO2002038805A8 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 07/05/2007 | US20070157329 use of amylases of the invention in starch conversion processes, including production of high fructose corn syrup (HFCS), ethanol, dextrose, and dextrose syrups; polypeptides having thermostable amylase activity |
| 07/05/2007 | US20070157327 Parkin interacting polypeptides and methods of use |
| 07/05/2007 | US20070157326 Ee3-protein family and corresponding dna sequence |
| 07/05/2007 | US20070157050 Process for providing submodel performance in a computer processing unit |
| 07/05/2007 | US20070155958 Tnf-like secreted protein |
| 07/05/2007 | US20070155955 Amylin aggregation inhibitors and use thereof |
| 07/05/2007 | US20070155801 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155691 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression |
| 07/05/2007 | US20070155689 Methods of regulating growth and death of cancer cells |
| 07/05/2007 | US20070155682 Translational control by small, non-translatable rnas |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
| 07/05/2007 | US20070155669 Prostate adenocarcinoma; bicalutamide non-steroidal anti-androgen, luteinizing hormone, luteinizing hormone-releasing hormone, LH-RH leuprorelin acetate agonist; microwave radiation by transurethral microwave thermoablation; laser; chemicals and radiation may or may not be administered simultaneously |
| 07/05/2007 | US20070155668 Peptides modulating the activity of the engrailed transcription factor |
| 07/05/2007 | US20070155667 Acute respiratory syndromes |
| 07/05/2007 | US20070155666 Canine and equine collagen joint health supplement |
| 07/05/2007 | US20070155665 Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| 07/05/2007 | US20070155664 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 07/05/2007 | US20070155663 Use of chemokine receptor agonists for stem cell transplantation |
| 07/05/2007 | US20070155662 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1a (pde1a) |
| 07/05/2007 | US20070155661 Methods and compositions for modulating the development of stem cells |
| 07/05/2007 | US20070155660 Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists |
| 07/05/2007 | US20070155659 Use of somatostatin or one of its analogues for preparing a medicament intended to regulate the ovarian follicular reserve in non-menopausal women |
| 07/05/2007 | US20070155657 Hypoglycemic agent |
| 07/05/2007 | US20070155656 Hypoglycemic agent |
| 07/05/2007 | US20070155655 Zinc (vitamin C)2 complex; low toxicity; insulin mimetics; stability; fat soluble; diabetes |
| 07/05/2007 | US20070155654 Novel formulations |
| 07/05/2007 | US20070155653 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.2% by weight of zinc based on the insulin content of the formulation; Polypeptide mixture containing preservative, surfactant and stabilizer |
| 07/05/2007 | US20070155652 Composition for regenerative treatment of cartilage disease |
| 07/05/2007 | US20070155651 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
| 07/05/2007 | US20070155650 Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases |
| 07/05/2007 | US20070155008 use of low-medium perfusion rates in an attached cell culture system to provide for improved yields; improved Ad-p53 production with cells grown in serum-free conditions; offers scalability, validatability and virus purity comparable to that achieved using CsCl gradient ultracentrifugation |
| 07/05/2007 | US20070154994 protein of an ectodomain of a transforming growth factor beta membrane-bound receptor and a peptide subunit of an alpha -helical coiled-coil; selecting compounds capable of inhibiting ligand binding and kinase activity |
| 07/05/2007 | US20070154992 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| 07/05/2007 | US20070154991 Transgenic bacillus for use as bioreactor in production of capsular polysaccharide A |
| 07/05/2007 | US20070154986 Streptococcus pneumoniae Polynucleotides and Sequences |
| 07/05/2007 | US20070154948 Novel antibacterial agents |
| 07/05/2007 | US20070154933 Reagents and Methods for Identifying Gene Targets for Treating Cancer |
| 07/05/2007 | US20070154920 For detecting and/or treating allergic dermatitis |
| 07/05/2007 | US20070154918 44 Human Secreted Proteins |
| 07/05/2007 | US20070154917 Compositions and method for treating viral infections |
| 07/05/2007 | US20070154912 87 Human Secreted Proteins |
| 07/05/2007 | US20070154910 50 Human Secreted Proteins |
| 07/05/2007 | US20070154908 Connective Tissue Growth Factor-2 |
| 07/05/2007 | US20070154905 Modulators of the function of fas receptors and other proteins |
| 07/05/2007 | US20070154901 Comprising tetranectin trimerising structural element (TTSE) capable of forming a stable complex with two other TTSEs; stability; used as a carrier of other chemical entities; drug delivery |
| 07/05/2007 | US20070154559 comprising 0.1-30 weight % complex of water-soluble drug and counter-ion substance in which charged water-soluble drug is bonded with counter-ion substance, 0.5-80 weight % lipid, 0.5-80 weight % polymer, and 1-80 weight % emulsifier; high gastrointestinal absorption rate; high drug entrapping rate |
| 07/05/2007 | US20070154556 Injectable gel-type bone-repairing material and preparing method thereof |
| 07/05/2007 | US20070154553 also contains a pharmacologically active substance and a stimulus-responsive compound comprising an azobenzene group or a stilbene group |
| 07/05/2007 | US20070154552 Biologically active native biomatrix composition |
| 07/05/2007 | US20070154534 Use of secretin in the treatment of schizophrenia |
| 07/05/2007 | US20070154530 Wound dressings comprising oxidized cellulose and human recombinant collagen |
| 07/05/2007 | US20070154529 Uses of dna binding proteins |
| 07/05/2007 | US20070154517 Methods and devices for promoting endothelial morphogenesis |
| 07/05/2007 | US20070154498 Intravenous essential fatty acid emulsion |
| 07/05/2007 | US20070154495 Modified whole cell, cell extract and omv-based vaccines |
| 07/05/2007 | US20070154488 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/05/2007 | US20070154486 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 07/05/2007 | US20070154474 Human Prostate Specific G-Protein Receptor HPRAJ70 |
| 07/05/2007 | US20070154467 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| 07/05/2007 | US20070154466 Internal medical devices containing peroxide-converting catalysts |
| 07/05/2007 | US20070154464 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell |
| 07/05/2007 | US20070154454 Compositions and methods for treating poxvirus infection |
| 07/05/2007 | US20070154453 have alterations in the IL-12p40 subunit to eliminate the protease site between positions Lys260 and Arg261; cancer, antiinflamatories |
| 07/05/2007 | US20070154452 Therapeutic agent for pancreas cancer |
| 07/05/2007 | US20070154451 Enhancer contains interleukin as an effective component and is co-administered with a recombinant herpes simplex virus that selectively replicates in cancer cells |
| 07/05/2007 | US20070154450 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 07/05/2007 | US20070154449 Tight junction modulating peptides for enhanced mucosal delivery of therapeutic compounds |
| 07/05/2007 | US20070154448 Methods and compositions using Substance P to promote wound healing |
| 07/05/2007 | US20070154446 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
| 07/05/2007 | US20070154437 Peptide-tagged proteins and methods of making and using thereof |
| 07/05/2007 | US20070154406 Spray-dried collectin compositions and process for preparing the same |
| 07/05/2007 | US20070154404 Insulin highly respirable microparticles |
| 07/05/2007 | US20070154402 Topical Pharmaceutical Foam Composition |